In8bioÂ Inc (INAB) Financials

$1.20

$0.04 (3.45%)

As on 04-Sep-2026 16:00EDT

Market cap

$12 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	1.67	2.50	2.66	2.50	1.10	0.25
Gross Profit	-1.67	-2.50	-2.66	-2.50	-1.10	-0.25
Operating Expenses	18.34	17.36	30.44	27.84	28.52	14.65
Operating Profit (EBIT)	-18.84	-19.86	-30.44	-30.34	-28.52	-14.65
Other Income	--	--	--	--	--	--
Profit before Tax	-18.67	-19.44	-30.44	-30.01	-28.52	-14.65
Provision for Tax	--	--	--	-32.84	-1.10	0.55
Profit after Tax (Net Income)	-18.67	-19.44	-30.44	-30.01	-27.42	-14.65
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-14.65

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	18.36	27.56	14.48	24.94	22.73	38.18
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.13	1.56	3.38	3.38	4.49	1.78
Current Liabilities	2.25	3.16	3.08	5.39	5.82	2.26
Total Liabilities	24.00	32.28	20.94	33.71	33.04	42.22

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.25	4.40	8.37	9.08	10.81	3.24
Current Assets	18.50	27.88	12.58	24.63	22.23	38.98
Total Assets	40.24	32.28	20.94	33.71	33.04	42.22
Total Debt*	2.18	2.78	5.03	4.89	5.87	2.41
Net Current Assets	--	24.72	9.50	19.23	16.41	36.72

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-12.71	-24.15	-23.34	-24.12	-13.51
Cash Flow from Investing Activities	--	--	-0.19	-0.60	-3.71	-0.31
Cash from Financing Activities	--	28.64	14.18	27.04	8.99	32.96
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.86	-1.99	-12.60	-25.14	-33.51	-23.41
Cash EPS ($)	--	-1.73	-11.50	-23.05	-32.16	-22.15
Adjusted Book Value ($)	--	2.82	5.99	20.90	27.78	61.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.30	-10.00	-19.56	-29.48	-21.58
Free Cash Flow per Share ($)	--	-1.30	-10.04	-20.06	-34.01	-22.07

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-78.00	-123.38	-102.70	-79.24	-49.60
ROE (%)	-81.30	-92.49	-154.44	-125.90	-90.02	-51.87
ROA (%)	-60.64	-73.05	-111.38	-89.91	-72.86	-46.42
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	18.89	34.32	1.36	-5.21	-94.64	-71.24
Net Profit Growth (%)	21.86	36.13	-1.43	-9.44	-87.12	-71.24
EPS Growth (%)	81.87	0.84	0.50	0.25	-0.43	-0.76
Book Value Growth (%)	-74.50	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.18	-0.02	-0.05	-0.07	-0.19
Price / Book Value	0.59	0.83	0.04	0.07	0.08	0.07
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.15	0.09	0.20	0.54	0.38	2.30
Close Price ($)	1.41	2.34	7.72	41.40	69.30	131.70
High Price ($)	2.73	12.53	57.90	118.50	149.40	309.57
Low Price ($)	1.17	1.17	6.51	19.50	41.40	128.40
Market Cap ($ Cr)	11.83	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.10	0.35	0.20	0.26	0.06
Short term debt to equity ratio	0.06	0.04	0.11	0.06	0.06	0.02
Current Ratio	8.21	8.82	4.08	4.57	3.82	17.28
Quick Ratio	8.21	--	--	--	--	--
Interest Coverage	--	--	--	--	-25.86	-18.60

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	50.97	90.32	220.16	411.61	738.50
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.